Skip to main content

Clinical Trial Results

Search

Dr. Masahiro Natsuaki and Dr. C. Michael Gibson Discuss: STOPDAPT-3: An Aspirin-Free antithrombotic strategy for percutaneous coronary intervention

Disclosures: TBD